Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Anticholinergics and ECT.

Barry Alan Kramer1

  • 1Department of Psychiatry and the Behavioral Sciences, University of Southern California School of Medicine, Los Angeles, California, USA.

Convulsive Therapy
|January 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A survey of the practice of electroconvulsive therapy in Asia.

The journal of ECT·2009
Same author

Use of the Neuro-Wrap system for severe post-electroconvulsive therapy headaches.

The journal of ECT·2008
Same author

ECT practice in Japan.

The journal of ECT·2005
Same author

Survey of the practice of electroconvulsive therapy in teaching hospitals in India.

The journal of ECT·2005
Same author

Electroconvulsive therapy practice in Thailand.

The journal of ECT·2004
Same author

Transcutaneous acupoint electrical stimulation in preventing and treating nausea and vomiting in patients receiving electroconvulsive therapy.

The journal of ECT·2003

Routine use of intravenous atropine before electroconvulsive therapy (ECT) is recommended. This review examines anticholinergic use in ECT, comparing agents and administration routes, despite limited large-scale trials.

Area of Science:

  • Anesthesiology
  • Neuroscience
  • Pharmacology

Background:

  • Anticholinergic medications are frequently administered before electroconvulsive therapy (ECT) anesthesia.
  • The necessity and routine use of these medications in ECT protocols are currently debated.
  • Historical context and supporting/refuting evidence for anticholinergic use in ECT are reviewed.

Purpose of the Study:

  • To review the historical basis and current evidence regarding the routine use of anticholinergics before ECT.
  • To compare different anticholinergic agents (atropine, glycopyrrolate, scopolamine) and routes of administration.
  • To evaluate the use of anticholinergics in conjunction with beta-blockers during ECT.

Main Methods:

  • Literature review of studies examining anticholinergic use in electroconvulsive therapy.

Related Experiment Videos

  • Comparative analysis of atropine, glycopyrrolate, and scopolamine.
  • Examination of administration routes and concurrent use with beta-blockers.

    • Main Results:

    • Evidence supporting the routine use of anticholinergics in ECT is limited, with few large, controlled trials.
    • Intravenous atropine is compared to other agents and administration methods.
    • The review considers the interplay between anticholinergics and beta-blockers in the context of ECT.

    Conclusions:

    • Despite the paucity of robust clinical trial data, routine intravenous atropine administration before ECT is recommended.
    • This recommendation is contingent upon the absence of specific contraindications for the patient.
    • Further research with larger patient cohorts is needed to definitively establish optimal anticholinergic protocols for ECT.